Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Oosterwijk

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medical Genetics|June 3, 2020
Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic <i>CDKN2A</i> variantsKasper A Overbeek, Mar Dm Rodríguez-Girondo, Anja Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factorsMirjam M de Jong, Ilja M Nolte, Gerard J Te Meerman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2017
CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary HyperparathyroidismKarin van der Tuin, Carli M J Tops, Muriel A Adank, et al.
International Journal of Cancer|May 3, 2014
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort studySepideh Saadatmand, Janet R Vos, Maartje J Hooning, et al.
Human Molecular Genetics|November 28, 2022
PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosisIrma van de Beek, Iris E Glykofridis, Jan C Oosterwijk, et al.
Menopause (New York, N.Y.)|June 22, 2016
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?Theodora C van Tilborg, Frank J Broekmans, Anouk Pijpe, et al.
BMC Cancer|October 4, 2012
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trialSepideh Saadatmand, Emiel J T Rutgers, Rob A E M Tollenaar, et al.
The New England Journal of Medicine|July 30, 2004
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Human Reproduction (Oxford, England)|December 2, 2016
Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?Theodora C van Tilborg, Inge A P Derks-Smeets, Anna M E Bos, et al.
Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medical Genetics|June 3, 2020
Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic <i>CDKN2A</i> variantsKasper A Overbeek, Mar Dm Rodríguez-Girondo, Anja Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factorsMirjam M de Jong, Ilja M Nolte, Gerard J Te Meerman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2017
CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary HyperparathyroidismKarin van der Tuin, Carli M J Tops, Muriel A Adank, et al.
International Journal of Cancer|May 3, 2014
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort studySepideh Saadatmand, Janet R Vos, Maartje J Hooning, et al.
Human Molecular Genetics|November 28, 2022
PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosisIrma van de Beek, Iris E Glykofridis, Jan C Oosterwijk, et al.
Menopause (New York, N.Y.)|June 22, 2016
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?Theodora C van Tilborg, Frank J Broekmans, Anouk Pijpe, et al.
BMC Cancer|October 4, 2012
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trialSepideh Saadatmand, Emiel J T Rutgers, Rob A E M Tollenaar, et al.
The New England Journal of Medicine|July 30, 2004
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Human Reproduction (Oxford, England)|December 2, 2016
Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?Theodora C van Tilborg, Inge A P Derks-Smeets, Anna M E Bos, et al.
Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.
Pageof 10